Microba Life Sciences Ltd Price, Chart & Factor Analysis
Free Data & Analytics AccessMicroba Life Sciences Ltd Forecast
Microba Life Sciences Ltd short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (1 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 51.9% a year, a typical one-standard-deviation range is 0.0334–0.0386 over a week, 0.0306–0.0414 over a month and 0.0173–0.0547 over a year. (Signals as of 21 Nov 2026.)
Microba Life Sciences Ltd Price Chart
Microba Life Sciences Ltd Factors
Research on Microba Life Sciences Ltd
Explore MacroFinance macro & markets research and analysis.
Microba Life Sciences Ltd Trading Strategies
31 backtested tactical asset allocation strategies hold EFA (developed markets outside the US), the closest tradable exposure to Microba Life Sciences Ltd; 22 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in EFA | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Butler's Elastic Asset Allocation - Offensive | Aggressive | Monthly | Premium · upgrade to view | |||
| Momentum Turning Points | Conservative | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Offensive | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's All-Weather Quad Momentum | Aggressive | Monthly | Premium · upgrade to view | |||
| Keller, Butler and Kipnis' Classical Asset Allocation - Defensive | Moderate | Monthly | Premium · upgrade to view | |||
| Livingston's Mama Bear (Muscular Portfolios) | Aggressive | Monthly | Premium · upgrade to view | |||
| Meb Faber's Global Tactical Asset Allocation 13 (GTAA 13) | Conservative | Monthly | Premium · upgrade to view | |||
| David Varadi's Minimum Correlation Portfolio | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Microba Life Sciences Ltd’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Microba Life Sciences Ltd (Australia)
Microba Life Sciences Ltd is a listed security in Australia. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Mapfre
Frequently asked questions
What is Microba Life Sciences Ltd?
What is the latest Microba Life Sciences Ltd price?
Is Microba Life Sciences Ltd in an uptrend?
How volatile is Microba Life Sciences Ltd?
What factors affect Microba Life Sciences Ltd?
Which trading strategies trade Microba Life Sciences Ltd?
How are Microba Life Sciences Ltd returns analysed?
Where can I download free Microba Life Sciences Ltd historical data?
Free Microba Life Sciences Ltd historical data (last 10 years)
Browse or instantly download the last 10 years of Microba Life Sciences Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MAP.AU&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-19 | 0.036 |
| 2026-11-18 | 0.036 |
| 2026-11-17 | 0.036 |
| 2026-11-16 | 0.036 |
| 2026-11-13 | 0.036 |
| 2026-11-12 | 0.035 |
| 2026-11-11 | 0.035 |
| 2026-11-10 | 0.035 |
| 2026-11-09 | 0.034 |
| 2026-11-06 | 0.037 |
About this stock
Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through, Testing Services and Supplements, and Research and Development segments. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; microba microbiome explorer; research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel autoimmune diseases, oncology, and allergy. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.